PDCD1 and neoplasm: To understand the mechanisms underlying anti–PD-1/anti-MIF–induced tumor regression, we first measured representative circulating cytokines and chemokines in plasma collected from YUMMER1.7 tumor–bearing mice prior to and after 2 doses of treatment.